SPI
19.020,19
PKT
-15,71
PKT
-0,08
%
Werbung
Analysen zu SPI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 22.04.16 | Novartis Underweight | Morgan Stanley | |
| 22.04.16 | Richemont buy | UBS AG | |
| 22.04.16 | Holcim market-perform | Bernstein Research | |
| 22.04.16 | Novartis Equal weight | Barclays Capital | |
| 21.04.16 | ABB (Asea Brown Boveri) Sell | Citigroup Corp. | |
| 21.04.16 | ABB (Asea Brown Boveri) Equal-Weight | Morgan Stanley | |
| 21.04.16 | Holcim Sell | Baader Wertpapierhandelsbank | |
| 21.04.16 | ABB (Asea Brown Boveri) Hold | Société Générale Group S.A. (SG) | |
| 21.04.16 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 21.04.16 | ABB (Asea Brown Boveri) Sell | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 21.04.16 | Holcim Hold | Kepler Cheuvreux | |
| 21.04.16 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 21.04.16 | UBS Neutral | UBS AG | |
| 20.04.16 | Roche overweight | Morgan Stanley | |
| 20.04.16 | ABB (Asea Brown Boveri) Halten | Independent Research GmbH | |
| 20.04.16 | Roche overweight | JP Morgan Chase & Co. | |
| 20.04.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 19.04.16 | Holcim Neutral | BNP PARIBAS | |
| 19.04.16 | Givaudan Sell | Société Générale Group S.A. (SG) | |
| 19.04.16 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 18.04.16 | Zurich Insurance Neutral | Citigroup Corp. | |
| 18.04.16 | Roche buy | UBS AG | |
| 15.04.16 | Nestlé Hold | Société Générale Group S.A. (SG) | |
| 15.04.16 | Novartis Neutral | UBS AG | |
| 15.04.16 | Nestlé Hold | HSBC | |
| 15.04.16 | Nestlé buy | Kepler Cheuvreux | |
| 15.04.16 | Nestlé overweight | JP Morgan Chase & Co. | |
| 15.04.16 | Swiss Re Hold | Baader Wertpapierhandelsbank | |
| 15.04.16 | Zurich Insurance buy | Baader Wertpapierhandelsbank | |
| 15.04.16 | Nestlé Underperform | BNP PARIBAS | |
| 15.04.16 | ABB (Asea Brown Boveri) Sell | Goldman Sachs Group Inc. | |
| 15.04.16 | Givaudan buy | Baader Wertpapierhandelsbank | |
| 14.04.16 | Swiss Re Neutral | Goldman Sachs Group Inc. | |
| 14.04.16 | Givaudan overweight | JP Morgan Chase & Co. | |
| 14.04.16 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 14.04.16 | UBS Market Perform | Cowen and Company, LLC | |
| 14.04.16 | Novartis Underweight | Barclays Capital | |
| 13.04.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 13.04.16 | Swiss Re Neutral | JP Morgan Chase & Co. | |
| 12.04.16 | Roche overweight | JP Morgan Chase & Co. |